您的位置: 首页 > 农业专利 > 详情页

HUMAN GASTROINTESTINAL MICROBIOME MODULATING COMPOSITION AND METHODS OF USE
专利权人:
MICROBIOME THERAPEUTICS LLC
发明人:
Mark L. HEIMAN,Dean P. STULL,Justin W. PENO
申请号:
US16545249
公开号:
US20190374570A1
申请日:
2019.08.20
申请国别(地区):
US
年份:
2019
代理人:
摘要:
A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充